Skip to main navigation Skip to search Skip to main content

Imeglimin, a novel glimin oral antidiabetic, exhibits good glycaemic control in type 2 diabetes mellitus patients

    Research output: Contribution to journal › Article › peer-review

    Original languageEnglish
    JournalDiabetologia.
    Volume53
    Publication statusPublished - 2010

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    OECD Field of Science

    • 3. Medical and Health Sciences

    Cite this